DeepVerge (DVRG), announced that the company’s unaudited revenues in H1 2022 grew by 95% to £6.47m (H1 2021: £3.32m). Orders to August of £8.87m are booked for delivery in H2

DeepVerge (DVRG), announced that the company’s unaudited revenues in H1 2022 grew by 95% to £6.47m (H1 2021: £3.32m). Orders to August of £8.87m are booked for delivery in H2
These are some of the most significant movers and losers on Aim in the last week.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Brave Bison, Berkeley
After being suspended pending its deal making since last year, San Leon (SLE), the independent oil and gas production, development and exploration company focused on Nigeria, announced that the suspension
Open Orphan (ORPH), a specialist contract research organisation, said it is developing the world’s first Omicron human challenge model.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Brandshield, Cornerstone, Eckoh, Essenys, Itaconix, Live
Petra Diamonds (PDL) announced an unaudited trading update for the three months ended 31 March 2022 and the nine months to 31 March 2022.
Zak Mir takes a charting look at some of the most followed small caps. Today’s selection includes Coro, Contango, Cyba, Conroy, Chill, Cornerstone, Genedrive, Joules, Kropz, Oxford Cannabinoid, Osirium, Simigon,
Zak Mir takes a charting look at some of the most followed small caps. Today’s selection includes Aminex, Castillo, Cornerstone, DeepVerge, Keras, Lansdowne, Mkango, Osirium, Pipehawk, Pembridge, Providence, Quantum.
After yesterday’s RNS from OKYO Pharma (OKYO), a biotechnology company, there was some leading from the front by Gabriele Cerrone, the Executive Chairman. He purchased 200,000 ordinary shares 5p and
DeepVerge (DVRG) confirmed that analysis to investigate the detection of SARS-CoV-2 virus on Microtox®PD chips coated with Optimers, binding agents provided by Aptamer Group (APTA), has detected 3 common variants